Latest filing published 02 Apr 2026 for Kiora Pharmaceuticals INC, €3,207. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Brian M. Strem is a declared insider of Kiora Pharmaceuticals Inc (chief executive), with filings sourced from SEC (Form 4). The record holds 10 filings, for trades running from 21 October 2021 to 1 April 2026.
On the market, this insider has only ever bought: 1 purchase, €14k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 9 share grants.
The record was last updated on 2 April 2026 with a share grant (€3,207) in Kiora Pharmaceuticals Inc. The most recent open-market purchase was published on 13 June 2024, 857 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations